Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Cefaclor manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

None products found

cefaclor

Oral suspension 125 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21177

This CTD dossier owner and manufacturer, established in the 1980s, operates within South Asia, specializing in the manufacture and supply of pharmaceutical products. Their offerings include tablets, capsules, eye, ear, and nasal drops, as well as oral and injectable suspensions. The company holds EU and US GMP approvals, signifying adherence to high manufacturing standards. Their production lines cater to a diverse range of therapeutic areas, with a focus on infectious diseases, pain management, and ophthalmology. The company boasts a sizable workforce and has a global reach, catering to markets across the world. They are recognized for their commitment to quality, utilizing high-grade chemicals and advanced machinery for production. The company emphasizes its track record in providing quality pharmaceutical products, underscoring its experience in the industry.

Manufacturer usually replies in 2 days

cefaclor

Granules for oral suspension 125 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20350

This company is a leading manufacturer of injectable and ophthalmic formulations, specializing in Beta Lactam and Cephalosporin products. They have a strong commitment to quality and compliance with international GMP standards (WHO-GMP & ISO 9001 : 2015). Their manufacturing facilities are dedicated to producing high-quality tablets, capsules, dry syrups, ointments, and sachets. They have a dedicated R&D center focused on innovation and export their products to over 30 countries. The company emphasizes sustainable manufacturing practices and environmental responsibility. Their client base includes hospitals, clinics, pharmacies, and government bodies across the globe.

Manufacturer usually replies in 13 days

cefaclor

Granules for oral suspension 125 mg/5 ml, 250 mg/5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18722
This pharmaceutical manufacturer boasts decades of experience in the industry, providing a broad range of affordable finished formulations, including prescription drugs, OTC medications, and supplements. They offer turnkey manufacturing, technology transfer, contract development and manufacturing services, as well as co-development and co-marketing options. Key therapy areas include chronic and acute therapies, OTCs, and complex formulations. Dosage forms include tablets, capsules, syrups, powders, liquids, injections, and ointments. They have obtained GMP approvals from regulatory bodies in the EU, North America, and other regions, demonstrating their commitment to quality and compliance. The company's global presence extends to key regions like North America, Asia, and Africa, solidifying their position as a trusted partner in the pharmaceutical industry.

Manufacturer usually replies in 13 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Cefaclor

Cefaclor is a second-generation cephalosporin antibiotic used to treat certain bacterial infections such as pneumonia and infections of the ear, throat, lung, skin, and urinary tract. Cefaclor is from a family of antibiotics called cephalosporins. They are broad-spectrum antibiotics used for the treatment of Septicaemia, meningitis, biliary tract infections pneumonia, peritonitis, and urinary tract infections. The makeup of the cephalosporins is similar to that of the Penicillins, excretion being principally renal. Cephalosporins’ ability to penetrate the cerebrospinal fluid is poor unless the meninges are already inflamed. Cefaclor is active against several bacteria, including both Gram-negative and Gram-positive organisms, in particular, targeted towards Haemophilus influenza, Staphylcoccus aureus, Streptococcus pyogenes. Cefaclor is marketed under the brand Ceclor among others. Eli Lily Italy is the main manufacturer & patent owner of Cefaclor. Cefaclor got patented in 1973 and approved for medical use in 1979.

Forms and Dosage

Cefaclor is sold as capsules and as extended-release tablets. In the treatment of Lower Respiratory Tract Infections, including pneumonia, caused by Streptococcus pneumoniae, Haemophilus influenzae, and Streptococcus pyogenes, the standard prescribed dose in Capsules is 250-500 mg every 8 hours. In the treatment of Otitis Media, Capsules of 250-500 mg are prescribed to be administered every 8 hours. In the treatment of Uncomplicated Skin and Skin Structure Infections, the recommended dosage is 250-500 mg every 8 hours or an Extended-release tablet of 375 mg taken every 12 for 7-10 days. In the treatment of Urinary Tract Infections and Bronchitis the dosage of extended-release tablets of 250 mg every 8 hours and in the treatment of Pharyngitis and Tonsillitis, the patients are prescribed Capsules of 250-500 mg, to be taken every 8 hours or Extended-release tablets of 750 mg given every 12 hours for 10 days.

The cost of Cefaclor

In the USA, the consumers have to pay an average retail price of $115 usd for a supply of 30 capsules of 500 mg strength. In the United Kingdom, the same supply of 30 tables would cost 122 Euros.

How does it work?

Cefaclor actions exert bactericidal activity by interfering with bacterial cell wall synthesis and inhibiting the cross-linking of the peptidoglycan. The cephalosporins play a role in the activation of bacterial cell autolysins which may contribute to bacterial cell lysis. Cefaclor's actions work by stopping the growth of bacteria. Cefaclor is used in only the treatment of bacterial infections.

Finding Cefaclor Manufacturers and Cefaclor Suppliers

One of the fastest and easiest ways to find Cefaclor manufacturers and Cefaclor suppliers is to make use of Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Usually, finding trusted manufacturers and supplies of specific drugs like Cefaclor can be a time- consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is make use of our integrated search engine and start looking for suppliers or manufacturers of Cefaclor to work with. You can fine-tune your search results using various filters too, letting you search for Cefaclor from specific countries, for example.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.